Premium
Screening for prostate cancer with serum prostate‐specific antigen
Author(s) -
Davis John W.
Publication year - 2008
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.23933
Subject(s) - medicine , prostatectomy , prostate cancer , prostate specific antigen , prostate , cancer , urology , antigen , oncology , gynecology , immunology
Nguyen et al compared the cancer recurrence‐free survival after radical prostatectomy among 2 groups of men diagnosed with prostate cancer due to an elevated serum prostate‐specific antigen (PSA): 1) those whose initial screening PSA was abnormal and 2) those with a history of previous normal screening PSAs. The study found group 1 to have more adverse pathologic features and recurrence‐free survival.